|
|
|
|
|
|
|
|
|
19.08.25 - 14:36
|
Charles River Associates (CRA) Expands Its Forensic Services Practice (Business Wire)
|
|
|
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Chris Rucinski has joined CRA as a Vice President in the Forensic Services Practice.
“We are delighted to welcome Chris to CRA,” said Paul Maleh, President and Chief Executive Officer of Charles River Associates. “With 15 years of experience at the intersection of intellectual property and complex technology disputes, Chris enhances our ability to advise clients and counsel in the resolution of high-stakes litigation. He joins a multidisciplinary team of forensic experts known for their analytical rigor and deep client commitment.”
“Chris brings exceptional depth in computer science and IP litigation,” said Kristofer Swanson, CRA Vice President and Practice Leader of Forensic Services. “He has testified as an expert in numerous high-profile matters and has consulted on more than 100 additional engagements. His ability ...
|
|
|
14.08.25 - 14:33
|
Charles River Associates (CRA) Strengthens Its Transfer Pricing Practice (Business Wire)
|
|
|
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Dr. Arin Mitra has joined CRA as a Vice President in the Transfer Pricing Practice.
“We are excited to welcome Arin to CRA,” said Paul Maleh, President and Chief Executive Officer of Charles River Associates. “He has more than three decades of experience with intercompany transactions and joins a growing and dynamic team committed to helping our clients with their most complex, cross-border tax issues.”
“Arin is recognized by his peers and industry publications as a top transfer pricing advisor,” said CRA Vice President and Transfer Pricing Practice Leader Rebel Curd. “In addition to providing expert testimony, he has managed large teams of tax professionals, advised multinational corporations on transfer pricing strategies and developed innovative software tools. We look forward to working with him on the most importa...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06.08.25 - 13:18
|
Charles River Laboratories Announces Second-Quarter 2025 Results (Business Wire)
|
|
|
– Second-Quarter Revenue of $1.03 Billion –
– Second-Quarter GAAP Earnings per Share of $1.06 and Non-GAAP Earnings per Share of $3.12 –
– Updates 2025 Guidance –WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter of 2025. For the quarter, revenue was $1,032.1 million, an increase of 0.6% from $1,026.1 million in the second quarter of 2024.
The impact of foreign currency translation increased reported revenue by 1.2%. Excluding this impact, revenue declined 0.5% on an organic basis. On a segment basis, an organic revenue decline in the Discovery and Safety Assessment (DSA) segment was partially offset by organic revenue growth in the Manufacturing Solutions (Manufacturing) and Research Models and Services (RMS) segments.
In the second quarter of 2025, the GAAP operating margin decreased to 9.7% from 14.8% in the second quarter of 2024. GAAP net income available to common shareholders for the second qua...
|
|
|
|
|
|
|
05.08.25 - 14:33
|
Charles River Associates (CRA) Expands Its Life Sciences Practice (Business Wire)
|
|
|
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Phoebe Ng and Chris Nüesch have joined CRA as Vice Presidents in the Life Sciences Practice.
“We are pleased to welcome Phoebe and Chris to CRA,” said Paul Maleh, President and Chief Executive Officer of Charles River Associates. “They are seasoned professionals with a proven track record of navigating complex challenges in areas ranging from portfolio strategy and product development to commercialization, market access, and brand growth.”
“Phoebe and Chris share CRA's data-driven approach and expertise in achieving meaningful outcomes for CRA's Life Sciences clients and we look forward to working with them,” said Dr. Gregory K. Bell, Group Vice President and Life Sciences Practice Leader. “Phoebe brings extensive experience across multiple therapeutic areas, with a strong track record of aligning long-term strategi...
|
|
|
31.07.25 - 14:06
|
Charles River Associates (CRA) Reports Financial Results for the Second Quarter of 2025 (Business Wire)
|
|
|
Broad-based Contributions Drive Record Quarterly Revenue
Company Increases Revenue Guidance and Raises Lower End of Profit Guidance for Full-Year Fiscal 2025BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced financial results for the fiscal second quarter ended June 28, 2025.
“Continued momentum in the business and demand for our services drove CRA's quarterly revenue to $186.9 million, representing 9.0% year-over-year growth and the highest quarterly revenue in the company's history,” said Paul Maleh, CRA's President and Chief Executive Officer. “Broad-based contributions supported the quarter's strong performance, with seven practices growing year over year. Our Antitrust & Competition Economics, Energy, Intellectual Property, and Labor & Employment practices each posted double-digit revenue growth. Geographically, our North American and international operations contributed to...
|
|
|
31.07.25 - 14:06
|
Charles River and BioTech Social Inc. Pursue Crowdfunding Partnership (Business Wire)
|
|
|
Aim to Enhance Charles River Incubator and Accelerator Programs by adding crowdfunding features, aiding early-stage developersWILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #LIFEatCRL--Charles River Laboratories International, Inc. (NYSE: CRL) and BioTech Social Inc. (BSI) today announced the exploration of a potential client-centric collaboration to enable Charles River Incubator (CIP) and Accelerator (CAP) Program participants to access the BioTech Funding Portal, an investment crowdfunding platform for life science companies.
“We're thrilled to explore this collaboration that will open up an exciting new funding pathway to bridge innovation with the right audiences and investors. This dynamic approach would potentially streamline the delivery of medicine to patients,” said Kerstin Dolph, Corporate Senior Vice President, Global Manufacturing, Charles River. “We're always working to equip our clients with the tools and opportunities they need to fast-track drug development and therapies.”
If formaliz...
|
|
|
|
|
|
|
22.07.25 - 22:51
|
Charles River Associates (CRA) Expands Executive Leadership Team (Business Wire)
|
|
|
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced the following management appointments, effective August 4, 2025:
Eric Nierenberg as Executive Vice President, Chief Financial Officer, and Treasurer;
Brian Langan as Executive Vice President and Chief Strategy and Business Transformation Officer; and
Sandra David as Principal Accounting Officer, in addition to her current roles as CRA's Chief Accounting Officer and Controller.
“I'm very pleased to see Eric and Brian elevated to executive officer roles at CRA, further strengthening our senior leadership team in a way that reflects the depth of talent within the organization and our deliberate, long-term commitment to strategic priorities,” said Paul Maleh, President and Chief Executive Officer of Charles River Associates.
“Since rejoining CRA in 2023, Eric has played a key role in helping several of our practices position themselv...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
